Biotage

Photo

Biotage Takes UK’s ATDBio

Sweden’s Biotage, a provider of systems and products for drug discovery and development, analytical testing and water and environmental testing, has acquired the UK’s ATDBio for about £45 million on a debt-free and cash-free basis.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.